HIGHLIGHTS
- who: Jingjing Zhou from the College, North Lishi Road, Xicheng, No167, Beijing, China have published the article: Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension, in the Journal: (JOURNAL)
- what: The authors aimed to examine the function of CacyBP/SIP in CHD-PAH and explore its potential as a novel regulatory target for the disease. All participants involved in this study provided written informed consent.
- how: The results indicated that CacyBP/SIP protected against pulmonary vascular remodeling through amelioration of hPASMC dysfunction in CHD-PAH . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.